HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmetics Diversified Stock Analysis: 1999

This article was originally published in The Rose Sheet

Executive Summary

1999 Performance Of Toiletries, Fragrances And Skin Care Stocks (11 Cosmetics and 10 Diversifieds) Used In "The Rose Sheet" Index: High, Low And Close For The Yea

You may also be interested in...



Avon CEO Selection, Growth Plan Sparks 33% Fourth Quarter Stock Runup

Avon's much-anticipated appointment of Andrea Jung to CEO coupled with her unveiling of the direct-seller's forward-looking business plan made the stock an eleventh-hour winner on Wall Street in 1999.

Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company

The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007552

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel